Preeclampsia, a complication characterized by high blood pressure during pregnancy, poses significant risks to both mother and child. Bioprinting placenta models offer researchers the ability to study the disease closely and develop targeted therapies. This could lead to breakthrough treatments, reducing the number of women and infants affected by this potentially life-threatening condition.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.